Fig. 5

Bar charts of the results of CyTOF analysis, performed on our COVID-19 patients. Results are expressed as mean values of the percentage of live cells and refers to healthy controls (light gray bars), COVID-19 patients with normal FT3 serum values (gray bars), COVID-19 patients with low FT3 serum values (dark gray bars) and COVID-19 patients with hematological malignancy and low FT3 serum values (black bars). a Absolute count of lymphocytes (CD45+), T-lymphocytes (CD3+), B-lymphocytes (CD19+), monocytes (CD14+), of Dendritic cells and of Granulocytes (CD15+); b absolute count of T-lymphocytes (CD3+/CD8+) and of their subtypes; c absolute count of T-lymphocytes (CD3+/CD4+) and of their subtypes; d absolute count of B-lymphocytes (CD19+) and their subtypes; e Absolute count of NK-cells (CD3-/CD56+) and their subtypes; f absolute count of monocytes (CD14+) and their subtypes; g absolute count of Granulocytes (CD15+) and their subtypes